The pharmaceutical industry is concerned that the United Kingdom’s exit from the EU will disrupt the European Medicines Agency’s activities. The organisation is currently based in London. In a joint statement published on Monday 24 April, several major players in the industry called for a soft and well thought out transition during the agency’s move.
The document is published on the European Federation of Pharmaceutical Associations and Industries’ website and is co-signed by the...